Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) is a
2-arm, multi-center, prospective, randomized, open-labeled, blinded-endpoint trial. The
purpose of this trial is to test whether a treatment program aimed at reducing systolic blood
pressure (SBP) to a lower goal (<130 mmHg, intensive treatment) than currently recommended
(<150 mmHg, standard treatment) will reduce CVD risk among persons between 60-80 years of
old. Furthermore, this trial will also examine the effect of blood pressure APP management
strategy via WeChat network on medication compliance, blood pressure control and CVD
benefits.
Phase:
N/A
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital